# Sero-prevalence COVID-19 Among Belgian Children

> **NCT04613817** · — · COMPLETED · sponsor: **Sciensano** · enrollment: 2103 (actual)

## Conditions studied

- SARS-CoV-2
- SARS-CoV Infection
- Covid19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04613817
- **Lead sponsor:** Sciensano
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-03
- **Primary completion:** 2021-12-17
- **Final completion:** 2021-12-31
- **Target enrollment:** 2103 (ACTUAL)
- **Last updated:** 2022-05-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04613817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04613817, "Sero-prevalence COVID-19 Among Belgian Children". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04613817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*